Safety and Efficacy of Low-Dose Bexarotene and PUVA in the Treatment of Patients with Mycosis Fungoides

被引：0
|
作者：
Evangelia Papadavid
Christina Antoniou
Vassiliki Nikolaou
Marina Siakantaris
Theodoros P. Vassilakopoulos
Alexandros Stratigos
Nikolaos Stavrianeas
Andreas Katsambas
机构：
[1] Athens University Medical School,1st Department of Dermatology
[2] Skin Lymphoma Clinic,2nd Department of Dermatology
[3] A Sygros Hospital,1st Department of Internal Medicine
[4] Athens University Medical School,Haematology
[5] ATTIKON University General Hospital,undefined
[6] Athens University Medical School,undefined
[7] Laikon General Hospital,undefined
来源：
American Journal of Clinical Dermatology | 2008年 / 9卷
关键词：
Fenofibrate; Mycosis Fungoides; Bexarotene; Overall Response; Immune Response Modifier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background:The new rexinoid bexarotene is a retinoid X receptor antagonist and immune response modifier. Although combinations of oral bexarotene and psoralen plus UVA (PUVA) have been tried in patients with all stages of mycosis fungoides (MF), the dosage of bexarotene used in these combination regimens has been variable.
引用
收藏
页码：169 / 173
页数：4
相关论文
共 50 条
  • [21] RESULTS OF A PROSPECTIVE PHASE II TRIAL OF ORAL LOW DOSE BEXAROTENE AND ULTRAVIOLET A PHOTOCHEMOTHERAPY (PUVA) FOR EARLY AND ADVANCED STAGE MYCOSIS FUNGOIDES
    Rupoli, S.
    Pimpinelli, N.
    Goteri, G.
    Canafoglia, L.
    Brandozzi, G.
    Federici, I.
    Giantomassi, F.
    Micucci, G.
    Scortechini, A.
    Da Lio, L.
    Ricotti, G.
    Simonacci, M.
    Filosa, G.
    Mozzicafreddo, G.
    Leoni, P.
    HAEMATOLOGICA, 2013, 98 : 360 - 361
  • [22] Treatment of childhood mycosis fungoides with topical PUVA
    Pabsch, H
    Rütten, A
    von Stemm, A
    Meigel, W
    Sander, CA
    Schaller, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (04) : 557 - 561
  • [23] Low dose Total Skin Irradiation followed by maintenance with oral Bexarotene in Mycosis Fungoides
    Simontacchi, G.
    Lo Russo, M.
    Marrazzo, L.
    Mangoni, M.
    Topulli, J.
    Teriaca, M. A.
    Ciabatti, C.
    Livi, L.
    Pimpinelli, N.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S376 - S376
  • [24] Low-dose methotrexate to treat mycosis fungoides: A retrospective study in 69 patients
    Zackheim, HS
    Kashani-Sabet, M
    McMillan, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (05) : 873 - 878
  • [25] Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene
    Talpur, Rakhshandra
    Duvic, Madeleine
    CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (06): : 488 - 492
  • [26] Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A
    Coors, EA
    von den Driesch, P
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) : 1379 - 1381
  • [27] Treatment of early stage mycosis fungoides with topical bexarotene
    Esposito, M.
    Giunta, A.
    Zangrilli, A.
    Ruzzetti, M.
    Bergamin, A.
    Nicoletti, M.
    Costanzo, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S40 - S40
  • [28] Bexarotene monotherapy for patients with advanced stage mycosis fungoides
    Bachelez, Herve
    DERMATOLOGIC CLINICS, 2008, 26 (01) : 25 - 26
  • [29] Comparison of the efficacy of treatment with clobetasol propionate or bexarotene in early-stage mycosis fungoides
    Cerman, Asli Aksu
    Cetinkaya, Pinar Ozdemir
    Kurt, Birgul Ozkesici
    Kirker, Artun
    Altunay, Ilknur
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2025, 100 (02) : 237 - 242
  • [30] TIME TO NEXT TREATMENT ANALYSIS FOR EARLY AND ADVANCED STAGES OF MYCOSIS FUNGOIDES / SEZARY SYNDROME TREATED WITH BEXAROTENE AND PUVA IN COMBINATION
    Rupoli, S.
    Goteri, G.
    Micucci, G.
    Federici, I.
    Canafoglia, L.
    Leoni, P.
    Brandozzi, G.
    Giantomassi, F.
    Mozzicafreddo, G.
    Alterini, R.
    Simonacci, M.
    Bugatti, L.
    Serresi, S.
    Santilli, R.
    Campanati, A.
    Pimpinelli, N.
    HAEMATOLOGICA, 2017, 102 : 466 - 467
12345